http://orcid.org/0000-0002-3567-3278
References
- Timmer CJ, Mulders TM. Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring. Clin Pharmacokinet. 2000;39:233–242.
- van den Heuvel MW, van Bragt AJ, Alnabawy AK, et al. Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive. Contraception 2005;72:168–174.
- Brache V, Payan JL, Faundes A. Current status of contraceptive vaginal rings. Contraception 2013;87:264–272.
- Hooper DJ. Attitudes, awareness, compliance and preferences among hormonal contraception users: a global, cross-sectional, self-administered, online survey. Clin Drug Investig. 2010;30:749–763.
- Mulders TM, Dieben TO. Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition. Fertil Steril. 2001;75:865–870.
- Algorta J, Diaz M, de Benito R, et al. Pharmacokinetic bioequivalence, safety and acceptability of Ornibel, a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with NuvaRing (etonogestrel/ethinylestradiol 11.7/2.7 mg). Eur J Contracept Reprod Health Care. 2017;22:429–438.
- Shastri PV. Toxicology of polymers for implant contraceptives for women. Contraception 2002;65:9–13.
- Miller L, MacFarlane SA, Materi HL. A scanning electron microscopic study of the contraceptive vaginal ring. Contraception 2005;71:65–67.
- Hardy L, Jespers V, De Baetselier I, et al. Association of vaginal dysbiosis and biofilm with contraceptive vaginal ring biomass in African women. PLoS One. 2017;12:e0178324.
- International Organization for Standardization. 2015. ISO 4287:1997 geometrical product specifications (GPS) – surface texture: profile method – terms, definitions and surface texture parameters [accessed 2019 Dec 11]. Available from: www.iso.org/standard/10132.html
- De Seta F, Restaino S, De Santo D, et al. Effects of hormonal contraception on vaginal flora. Contraception 2012;86:526–529.
- Brache V, Faundes A. Contraceptive vaginal rings: a review. Contraception 2010;82:418–427.
- Tang H, Cao T, Liang X, et al. Influence of silicone surface roughness and hydrophobicity on adhesion and colonization of Staphylococcus epidermidis. J Biomed Mater Res. 2009;88:454–463.
- Crucitti T, Hardy L, van de Wijgert J, et al. Contraceptive rings promote vaginal lactobacilli in a high bacterial vaginosis prevalence population: a randomised, open-label longitudinal study in Rwandan women. PLoS One. 2018;13:e0201003.
- Camacho DP, Consolaro ME, Patussi EV, et al. Vaginal yeast adherence to the combined contraceptive vaginal ring (CCVR). Contraception 2007;76:439–443.
- Chassot F, Camacho DP, Patussi EV, et al. Can Lactobacillus acidophilus influence the adhesion capacity of Candida albicans on the combined contraceptive vaginal ring? Contraception 2010;81:331–335.
- Sailer M, Colli E, Regidor PA. In vitro evaluation of microbial adhesion to a contraceptive vaginal ring with a new polymer composition. Eur J Contracept Reprod Health Care. 2019;24:188–191.
- Baeten JM, Palanee-Phillips T, Brown ER, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med. 2016;375:2121–2132.
- Young Holt B, Dellplain L, Creinin MD, et al. A strategic action framework for multipurpose prevention technologies combining contraceptive hormones and antiretroviral drugs to prevent pregnancy and HIV. Eur J Contracept Reprod Health Care. 2018;23:326–334.
- Grandi G, Barra F, Ferrero S, et al. Estradiol in non-oral hormonal contraception: a ‘long and winding road’. Expert Rev Endocrinol Metab. 2019;14:153–155.